AMICUS THERAPEUTICS, INC. — Director's Dealing 2010

Jun 16, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2010-06-15

Reporting Person: RAAB MICHAEL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-06-15	Stock Options (right to buy)	$2.81	A	10000	Acquired	2020-06-15	Common Stock (10000)	Direct

Footnotes

F1: One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2011, provided that if the reporting person ceases to be a director of the issuer, this option shall cease to be exercisable in any respect not later than ninety (90) days following that event.